Issue 973: January 17, 2012

TOP STORIES

VACCINE INFORMATION STATEMENTS

FEATURED RESOURCES

EDUCATION AND TRAINING



TOP STORIES

Spotlight on immunize.org: Visit "What's New at IAC"
Looking for just-released handouts for staff and patients and for new VISs and their translations from IAC? Look no further. The "What's New at IAC" web section offers visitors a chronological list of new and revised materials. At the bottom of the section, you'll find easy access to materials posted in 2011 and in years going back to 2008.

To help users find selected materials of interest, the entries in "What's New at IAC" are also organized into three subcategories:
Back to top


CDC publishes surveillance report on chronic hepatitis B virus infections in New York City
CDC published Surveillance for Chronic Hepatitis B Virus Infection—New York City, June 2008–November 2009 in the January 13 issue of MMWR (pages 6–9). The first paragraph is reprinted below.

Chronic hepatitis B virus (HBV) infection is a leading cause of cirrhosis and liver cancer worldwide; the estimated prevalence in the United States is 0.3%–0.5%. Each year, approximately 11,500–13,000 persons are newly reported with a positive HBV test to the New York City (NYC) Department of Health and Mental Hygiene (DOHMH). To characterize chronic HBV patients, DOHMH began ongoing enhanced chronic HBV surveillance, selecting a random sample of newly reported cases and collecting more detailed information from the patients' clinicians. This report summarizes investigations of 180 randomly selected HBV cases reported during June 2008–November 2009. Approximately two thirds (67%) of patients were Asian, and the most commonly reported reason for HBV testing was the patient's birth country or race/ethnicity (27%). In 70% of cases, the clinician did not know of any patient risk factors. Sixty-nine percent of clinicians stated that they counseled their patients about notifying close contacts about their infection, and 75% counseled about transmission and prevention. Sixty-two percent did not know their patient's hepatitis A vaccination status despite recommendations. This surveillance effort provided quantitative data on health disparities useful for identifying opportunities for outreach and education, and it showed that not all patients received recommended prevention and treatment services. In response to these findings, DOHMH now routinely distributes HBV patient education materials to populations in need.

Back to top


The Philippines will begin vaccinating children against rotavirus infection in 2012
On January 10, the PATH email news alert service RotaFlash announced that the Philippines will begin vaccinating children against rotavirus infection in 2012, making the island nation the first in Southeast Asia to implement the World Health Organization's 2009 recommendation to introduce life-saving rotavirus vaccines through its national immunization program.

An international nonprofit organization, PATH creates sustainable, culturally relevant solutions that enable communities worldwide to break longstanding cycles of poor health. RotaFlash is the email news alert service of PATH's Rotavirus Vaccine Program.

Back to top


VACCINE INFORMATION STATEMENTS

IAC posts Spanish, Arabic, and Chinese VISs for HPV (Cervarix) and hepatitis A vaccines (also in Thai)
IAC recently posted seven new VIS translations on its website. The VIS for HPV (Cervarix) vaccine is now available in Spanish, Arabic, and Chinese. The VIS for hepatitis A vaccine is now available in Spanish, Arabic, Chinese, and Thai. IAC thanks Asian Pacific Health Care Venture for the Thai translation.
Back to top


FEATURED RESOURCES

Influenza vaccination is recommended for almost everyone, so please keep vaccinating
Influenza vaccination is recommended for everyone age 6 months and older, so please keep vaccinating your patients.

Following is a list of resources related to influenza disease and vaccination for healthcare professionals and the public.
Back to top


CDC's new atlas to provide access to data on HIV/AIDS, viral hepatitis, STDs, and tuberculosis
On January 9, the Department of Health and Human Services (HHS) posted a "Dear Colleague" letter announcing that CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) has released an atlas that presents surveillance data for HIV, AIDS, chlamydia, gonorrhea, and primary and secondary syphilis. TB and viral hepatitis surveillance data will be added by mid-year.

Back to top


EDUCATION AND TRAINING

American College of Physicians' webinar on efficient vaccine ordering planned for February 23
The American College of Physicians has scheduled a webinar on efficient vaccine ordering for 5PM ET on February 23. Registrations are now being accepted.

Back to top




About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .